Jeffrey McCracken

Amgen eyeing potential acquisitions

Amgen and Celgene may dive into deal-making this year as the biggest biotechnology companies seek to return to the industry's high-growth roots

AT&T tries to sell assets to save T-Mobile bid

AT&T is approaching smaller rivals including MetroPCS Communications and Leap Wireless International to sell spectrum and subscribers, said two people with direct knowledge of the...

Kerkorian hungry for GM

Billionaire investor and Las Vegas casino mogul Kirk Kerkorian has made an $870 million offer to become one of the largest shareholders...